Grand Rounds and Patient Viewing

In-person, Herbst Hall, 1600 Divisadero Street, 2^nd Floor, Hospital Side

RNA-Based Therapeutics: New Frontier in Pharmacological Strategies

Susana Ortiz, MD, PHD, MBA, Associate Professor of Dermatology, UCSF

Objectives:

• Recognize mechanisms of action for RNA-Based Therapeutics
• Describe Challenges/Solutions and Clinical application of RNA-Based Therapeutics
• Introduce RNA regulators in melanoma & other cancers: Potential novel targets

Speaker Disclosures: Susana Ortiz, MD, PhD, MBA, has not completed the disclosure form. 

Moderator Disclosures: Katrina Abuabara, MD, MA, MSCE has disclosed that she is a consultant for Target RWE, Neetkar Therapeutics, Sanofi and Amgen. She receives research grants from Pfizer and Cosmetique International SNC. She is an advisor or reviewer for Amgen.

Planner Disclosures: Hunter Shain, PhD has disclosed that he has an industry sponsored reserach agreement with Kenview. Kelly Cordoro, MD and Amanda Twigg, MD have stated they have no relationships to disclose.